BCDA
BioCardia, Inc.
Key Financials
Net Income
$-8228000
↓ 3.5%
Operating Income
$-8278000
↓ 3.5%
Gross Profit
$62000
↑ 416.7%
Revenue
$479000
↓ 16.8%
EPS (Diluted)
$-0.21
N/A
Total Liabilities
$2.5M
↓ 12.8%
Shareholders' Equity
$895000.00
↑ 6.9%
Cash & Equivalents
$2.5M
↑ 5.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 7/1/2026 | View on SEC |
| 4 | 7/1/2026 | View on SEC |
| 4 | 7/1/2026 | View on SEC |
| 4 | 6/24/2026 | View on SEC |
| 4 | 6/22/2026 | View on SEC |
| 8-K | 6/18/2026 | View on SEC |
| 8-K | 6/12/2026 | View on SEC |
| 4 | 6/9/2026 | View on SEC |
| 8-K | 6/8/2026 | View on SEC |
| 8-K | 6/5/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BCDA |
| Company Name | BioCardia, Inc. |
| CIK | 925741 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 650-226-0123 |